Search

Search results

1498 results found

Occupation and risk of parkinsonism: a multicenter case-control study

Publication: Journal Article

Tanner, CM, GW Ross, SA Jewell, RA Hauser, J Jankovic, SA Factor, S Bressman, et al. 2009. “Occupation and Risk of Parkinsonism: A Multicenter Case-Control Study”. Arch Neurol.

Levodopa/carbidopa/entacapone 200/50/200 mg (Stalevo 200) in the treatment of Parkinson’s disease: a case series

Publication: Journal Article

Sethi, KD, RA Hauser, SH Isaacson, and T McClain. 2009. “Levodopa/Carbidopa/Entacapone 200/50/200 Mg (Stalevo 200) in the Treatment of Parkinson’s Disease: A Case Series”. J Cases.

Chorea as a side effect of gabapentin (Neurontin) in a patient with complex regional pain syndrome Type 1

Publication: Journal Article

Zesiewicz, TA, WR Shimberg, RA Hauser, W Robinson, MC Wilson, and KL Sullivan. 2008. “Chorea As a Side Effect of Gabapentin (Neurontin) in a Patient With Complex Regional Pain Syndrome Type 1”. Clin Rheumatol.

Caffeine and Progression of Parkinson Disease.

Publication: Journal Article

Simon, DK, CJ Swearingen, RA Hauser, JM Trugman, MJ Aminoff, C Singer, D Truong, and BC Tilley. 2008. “Caffeine and Progression of Parkinson Disease.”. Clin Neuropharmacol.

Study of istradefylline in patients with Parkinson's disease on levodopa with motor fluctuations.

Publication: Journal Article

Hauser, RA, LM Shulman, JM Trugman, JW Roberts, A Mori, R Ballerini, and NM Sussman. 2008. “Study of Istradefylline in Patients With Parkinson’s Disease on Levodopa With Motor Fluctuations.”. Mov Disord.

Medical treatment of motor and nonmotor features of Parkinson’s disease.

Publication: Journal Article

Zesiewicz, TA, and RA Hauser. 2007. “Medical Treatment of Motor and Nonmotor Features of Parkinson’s Disease.”. Continuum.

Randomized trial of the triple monoamine reuptake inhibitor NS 2330 (tesofensine) in early Parkinson’s disease.

Publication: Journal Article

Hauser, RA, L Salin, N Juhel, and VL Konyago. 2007. “Randomized Trial of the Triple Monoamine Reuptake Inhibitor NS 2330 (tesofensine) in Early Parkinson’s Disease.”. Movement Disorders.

Initial management of Parkinson’s disease in a Florida community. J Applied Research 2004;4:95-98.

Publication: Journal Article

Zesiewicz, TA, SN Carter, KL Sullivan, JS Staffetti, PB Dunne, and RA Hauser. 2004. “Initial Management of Parkinson’s Disease in a Florida Community. J Applied Research 2004;4:95-98.”. J Applied Research.

Yao Wei Lu

Person: PhD, Assistant Professor

Yao Wei Lu received his Ph.D. from the Department of Cellular and Molecular Physiology at Albany Medical College in John Schwarz's laboratory, where he studied the role of transcription factor MEF2 in the vasculature. He worked with Da-Zhi Wang to investigate the multifaceted roles of RNA-binding...

Mengmeng Chang

Person: Postdoctoral Research Scholar

I obtained my MD degree in China, 2016 and received my Ph.D. degree from the department of Molecular Pharmacology and Physiology at USF Morsani College of Medicine, in 2022. During my five-year Ph.D. study, with the guidance from my PHD mentor, I found that protein kinase C epsilon contributes to...